Mallinckrodt PLC (NYSE:MNK) dropped 0.7% on Monday . The company traded as low as $73.16 and last traded at $74.41, with a volume of 882,053 shares traded. The stock had previously closed at $74.92.

MNK has been the topic of a number of recent analyst reports. TheStreet upgraded Mallinckrodt PLC from a “hold” rating to a “buy” rating in a research report on Friday, June 17th. Wells Fargo & Co. restated a “buy” rating on shares of Mallinckrodt PLC in a research report on Friday, June 10th. Mizuho restated a “buy” rating on shares of Mallinckrodt PLC in a research report on Monday, June 6th. Zacks Investment Research upgraded Mallinckrodt PLC from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a research report on Thursday, May 5th. Finally, Oppenheimer Holdings Inc. restated a “buy” rating on shares of Mallinckrodt PLC in a research report on Wednesday, May 4th. Four research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Mallinckrodt PLC has a consensus rating of “Buy” and an average target price of $94.82.

The company’s 50 day moving average price is $72.53 and its 200-day moving average price is $64.52. The stock has a market capitalization of $7.99 billion and a P/E ratio of 13.99.

Mallinckrodt PLC (NYSE:MNK) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $2.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.00 by $0.20. The firm earned $970.60 million during the quarter, compared to the consensus estimate of $920.35 million. During the same period last year, the company earned $2.05 EPS. The firm’s revenue for the quarter was up .6% compared to the same quarter last year. On average, equities analysts forecast that Mallinckrodt PLC will post $7.72 EPS for the current year.

A hedge fund recently raised its stake in Mallinckrodt PLC stock. Ameriprise Financial Inc. boosted its stake in Mallinckrodt PLC (NYSE:MNK) by 69.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 617,468 shares of the company’s stock after buying an additional 252,605 shares during the period. Ameriprise Financial Inc. owned approximately 0.55% of Mallinckrodt PLC worth $46,089,000 as of its most recent SEC filing.

Mallinckrodt public limited company (Mallinckrodt) is engaged in the specialty pharmaceuticals and nuclear imaging business. The Company develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents. The Company’s segments include Specialty Brands, Specialty Generics and Nuclear Imaging.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.